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14C has long been used as a tracer for quantifying the in vivo human metabolism of food components,
biopharmaceuticals, and nutrients. Minute amounts (e1   10
-18 mol) of
14C can be measured with
high-throughput
14C-accelerator mass spectrometry (HT
14C-AMS) in isolated chemical extracts of
biological, biomedical, and environmental samples. Availability of in vivo human data sets using a
14C tracer would enable current concepts of the metabolic behavior of food components, biophar-
maceuticals, or nutrients to be organized into models suitable for quantitative hypothesis testing and
determination of metabolic parameters. In vivo models are important for specification of intake levels
for food components, biopharmaceuticals, and nutrients. Accurate estimation of the radiation
exposure from ingested
14C is an essential component of the experimental design. Therefore, this
paper illustrates the calculation involved in determining the radiation exposure from a minute dose of
orally administered
14C-β-carotene,
14C-R-tocopherol,
14C-lutein, and
14C-folic acid from four prior
experiments. The administered doses ranged from 36 to 100 nCi, and radiation exposure ranged
from 0.12 to 5.2 μSv to whole body and from 0.2 to 3.4 μSv to liver with consideration of tissue
weighting factor and fractional nutrient. In comparison, radiation exposure experienced during a 4 h
airline flight across the United States at 37000 ft was 20 μSv.
KEYWORDS:
14C tracer; radiation exposure calculation; in vivo in human; accelerator mass spectrometry
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INTRODUCTION
Carbon-14 (
14C) is a radioactive isotope of carbon that is pro-
duced by nitrogen-14 (
14N) capture of thermal neutrons gene-
rated from cosmic rays (
1nþ
14N f
14Cþ
1H) (1,2). The natural
abundance of
14Ci s1 . 2  10
-10%( 2, 3).
14C has long half-life
(t1/2=5730 years), and it decays to nonradioactive
14Nt h r o u g h
radioactive β-decay, which emits an electron and an antineutrino
(2-6). Due to very low natural abundance and long half-life,
14C
is an ideal tracer for environmental as well as in vivo human or
animal studies.
Traditionally,
14C has been measured using decay counters such
as a liquid scintillation counter (LSC). LSC usually requires a
gram-sized carbon sample and long measuring time (>48 h) to
obtain a statistical precision of e1% (4, 5). Conventional mass
spectrometry (MS) was also an alternative technique to detect
variousisotopes. However, isotopessuchas
14C with rare natural
abundance cannot be detected for lack of sensitivity of conven-
tional MS (detection limit of
14C/
12C ratio using MS, g1 10
-7,
vs ambient level of
14C/
12Cr a t i o ,1  10
-12) and for isobar
interference (
14Cv s
14N,
12CH2
-,
12CD,
13CH1
-)( 5-9).
Accelerator mass spectrometry (AMS) is the ultimate techni-
que to measure long-lived isotopes such as
14C due to extremely
high selectivity and sensitivity. AMS was first developed in the
early 1930s (10), but it was not used for
14C measurement until
1977 due to atomic isobar interference with
14N( 11). Develop-
ment of the cesium sputter (Cs
þ)m e t h o dt og e n e r a t e
14C
-
negative ions enabled AMS to be used for radiocarbon dating
(5,8,12,13).
14N does not form stable
14N
- ions.
AMS methods for various radioisotopes were developed to
advance specific research objectives: radiocarbon dating (
14C),
biological/biomedical study (
3H,
14C,
26Al,
41Ca,
129I), nuclear
weapon testing (
41Ca), monitoring migration of nuclear waste
from nuclear power plant (
36Cl,
129I), hydrogeological study
(
10He,
36Cl), and exposure dating (
10Be,
26Al,
36Cl) (5).
14Cw a s
the most popular radioisotope measured with AMS (3,5). AMS
measured the
14C/
12Co r
14C/
13C ratio (rather than
14Cd e c a y )i n
samples of interest and thereby increased sensitivity to the
attomole (10
-18) level, making AMS 1000 times more sensitive
than LSC (3,5,14). AMS required a milligram or less of carbon
(emg of C). Sample mass for AMS was 1000 times less than that
for LSC (3-5,8,14). Furthermore, AMS achieved a precision of
≈1% in 5-10 min (3-6). The great efficiency and sensitivity
madeAMStheultimatetoolforquantifyingmetabolicbehaviors
of food components, nutrients, and biopharmaceuticals using a
14Ct r a c e r .
Biological/biomedical applications using AMS were first sug-
gested≈30yearsago(15),andtheseapplicationsbeganinearnest
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in the early 1990s (16). In vivo in human or in vivo in animal
dynamic and kinetic behaviors, absorption, distribution, meta-
bolism, elimination (ADME) of food component, nutrients
(17-21), or environmental chemicals (22-24)u s i n g
14C-AMS
have been reported during the past two decades.
For biological/biomedical
14C-AMS applications, very small
amounts of
14C-labeled compound were administered to humans
and commonly called microdosing in drug development studies.
The U.S. Food and Drug Administration (25) and European
Medicines Agency (26) defined microdosing as only 1% of a
therapeutic dose or e100 μg/person. Because pharmacokinetics
(PK) with microdosing was ≈70% equivalent of a PK with
therapeutic dose (27), microdosing combined with AMS enabled
physiological-based (steady-state) kinetic/dynamic behavior
study of food components or nutrients to be conducted. Thus,
AMS methods led to better understanding of in vivo in human
metabolism of food components or nutrients (14). The combina-
tionofmicrodosing and AMS alsominimizedthe riskoftoxicity,
cost, time, and labor, especially for new drug development in the
pharmaceutical industry (4).
Thetypicalradiationexposureexperiencedduringa4hairplane
ride at 37000 feet altitude was 20 μSv (28). The radiation exposure
of 20 μSv was considered to be an acceptable level of exposure in
the United States, so 20 μSv is used as a reference level. Human
radiation exposure calculation from the administered
14C-labeled
food components or nutrients is an integral part of protocols for
biological/biomedical AMS applications. Therefore, the present
studyreported apracticaland completemethod forcalculatingthe
14C radiation exposure during the conduct of our four prior
studies (18-21). The method took into account
14C dose level,
body mass, biological half-life of
14C-labeled nutrients, tissue
weightingfactor(radiationexposureinanorganand/ortissuerela-
tive to that of the whole body mass in dimensionless multiplicative
factor), and fractional nutrient content in each organ or tissue.
MATERIALS AND METHODS
Subject Selection. Human subjects who were healthy nonsmoking
adults aged 20-60 years with a BMI of 20-37.5 kg/m
2 were recruited
(Table 1). Written informed consent was obtained from volunteers per
University of California;Davis (UCD) and Lawrence Livermore Nati-
onal Laboratory (LLNL) Human Subjects Review Committees. All studies
wereperformedwithGoodClinicalPracticeGuidelines(ver.1989)andthe
ethical guidelines of the 1975 Declaration of Helsinki (18-21).
DoseAdministration.Table1summarizesthe
14Cdose,nutrientdose,
etc. in each study (18-21). Nutrients were chemically (β-carotene,
R-tocopherol) or biologically (lutein, folic acid) labeled with
14C.
14C-Nutrients (36-100 nCi) were orally administered to human subjects
with breakfast. Oral dose administration was also approved by the UCD
and LLNL Human Subjects Review Committees prior to
14C-nutrient
studies (18-21). A small ratio (mol/mol) of
14C-nutrient dose to Recom-
mend Dietary Allowances (RDA) was necessary for the physiological-
based (steady-state)
14C-tracer study. The RDAs of β-carotene and lutein
were not decided yet, so U.S. average intake (AI) was considered for
steady-state
14C-tracer study.
Sample Collections. Prior to
14C-nutrient dose, fasting plasma,
urine, and feces were collected for
14C baselines of each human subject.
Serial plasmas, urines, and feces were collected over time since
14C-nutrient
dose (18-21). A predose baseline blood sample was collected. Addi-
tional blood samples were usually collected at every 0.5 h interval
from 0 to 12 h, hourly from 12 to 16 h, and then at 24 and 36 h after
14C-nutrient dose. Subsequent blood samples were collected daily from
2 to 7 days, every other day from 7 to 14 days, then weekly, biweekly,
and/or monthly for the remainder of the study. In addition, prior to
dosing
14C-nutrient in each study, a complete collection of feces and
urine was also taken to establish baseline values. Serial collections of
feces and urine usually continued for 14 and 21 days, respectively,
after the day of
14C-nutrient dosing. Durations of β-carotene, lutein,
R-tocopherol, and folate studies were 5, 3, 3, and 6 months, respec-
tively. When 100 nCi of
14C was dosed to the 70 kg human subject,
collected samples had 0.0014 nCi of
14C/g, a level considered to be
nonradioactive according to the U.S. Code of Federal Regulations,
Title 10, Section 20.2005, 1991 (cutoff, e50 nCi/g or 1 μCi/year),
enabling waste to be disposed of as nonradioactive waste.
Graphitization. All reagents and materials for sample preparation
(18-21) and graphitization/
14C-AMS measurement (29-31)w e r ep r e -
viously described and are summarized below. High-throughput (HT)
14C-AMS applications usually required 1 mg of C sample, so carbon con-
tent in the sample of interest was measured (32). Prior to
14C-AMS mea-
surement, samples of interest were converted to elemental carbon, usually
graphite-like materials. Sample preparation (often called graphitization)
consisted of oxidation (combustion: sample f CO2) and reduction
(graphitization: CO2 f Cgraphite-like materials) steps. We have previously used
three different graphitization methods for β-carotene (31), lutein (31),
R-tocopherol (29, 30), and folic acid (29) studies. Recently, we optimized
our graphitization method (maximum 270 samples/day) for accurate and
precise HT-
14C-AMS measurement (33). More information about graphi-
tization is included in the Supporting Information (Figure 1; Table 1).
14C-AMS Measurement. One million voltage AMS at the Center
for AMS at LLNL (see Supporting Information, Figure 2) measured
Table 1. Summary of Our Prior
14C-Labeled Nutrient Studies (18-21) and Daily Reference Nutrient Amounts
R-tocopherol (20)
unit β-carotene (18) lutein (19) RRR
a all-rac
a folic acid (21)
molecular weight g/mol 536.873 568.9 430.71 430.71 441.4
specific activity, SA Ci/mol 98.8(18) 0.2888 56 60 1.24
b
gender male (n =4 ) female (n =1 ) male (n =1 ) male (n =1 ) male (n =7 )
female (n =4 ) female (n =6 )
subject kg 76.7 ( 23.2 64.1 79.5 79.5 78.3 ( 0.28
body mass index kg/m
2 25.0 ( 4.2 27.6 23.8 23.8 26.5 ( 5.9
age year 35 ( 8.2 45 36 36 32 ( 0.38
14C dose (18-21) nmol [nCi] 1.01 [100] 125 [36] 1.821 [101.5] 1.667 [99.98] 0.5 [100]
ratio (mol/mol) between
14C dose (18-21)
and Recommended Daily Allowance (RDA)
or average intake (AI) in the U.S.
1/6544 1/3 through 1/28 1/19124 1/20891 1/1812 (>19 years)
1/2719 (pregnancy)
reference nutrient amount/day
RDA or AI in the U.S. mmol/day 0.0066
(AI) (17)
0.0003-0.0035
(AI) (38)
0.0348 (>19 years)
(RDA) (39)
0.0009 (>19 years)
0.0014 (pregnancy)
(RDA) (40)
therapeutic level mmol/day ≈0.32 (39) 0.011-0.018 (38) 0.12-7.43 (41) 0.0005-0.022 (41)
tolerable upper intake level/day mmol/day nd
c (39)n d ( 39) 2.32 (>19 years) (39) 0.0023 (>19 years) (40)
aThe study design was a test and retest in one subject.
bSA was determined by using a mix of 0.5 nmol of
14C-folic acid and 79.5 nmol of nonlabeled cold folic acid.
cThe
Institute of Medicine at the National Academy of Sciences did not establish a Tolerable Upper Intake Level (UL) for carotenoids when it reviewed these compounds in 2000.4634 J. Agric. Food Chem., Vol. 58, No. 8, 2010 Kim et al.
14C/
13C ratios fromgraphitized solid samples. Measured
14C/
13Cr at io s
of samples were normalized with one of the popular AMS standards
such as oxalic acid, NIST SRM 4990B/4990C, or sucrose, IAEA-C6
(34,35). Finally,
14C level in samples was defined as “Modern or Frac-
tion Modern (Fm)”. A current/natural
14C level in living organisms
is about 1.1 Fm (= 107.6 amol of
14C/mg of C, 6.72 fCi/mg of C, or
14.92 dpm/g of C) (30, 36).
Human Radiation Exposure Calculation from
14C Dose. Radia-
tion exposure from
14C-labeled nutrient was calculated (3)a s
exposure ¼
Ed
Md
  dose  
Z ¥
0
et=τbio dt
¼
Ed
Md
  τbio   dose   WT   FN ð1Þ
where Ed is energy deposition per decay as joules (8.3 fJ/decay), Md is the
affected mass (kg), dose is the amount of radioactivity in dpm, τbio is
the biological mean-life of
14C-labeled compound in minutes or seconds,
WTistissueweightingfactor(radiationexposureinanorganand/ortissue
relative to that of the whole body (WB) in dimensionless multiplicative
factor(seeSupportingInformation,Table2)(37),andFNisthefractional
nutrient content in each organ or tissue (see Supporting Information,
Table 2).
Radiation exposure was calculated previously without considering
WT and the FN (3). The formula (eq 1) for radiation exposure estimation
was modified by considering WT for each organ as well as different FN.
The formula (eq1) can morecompletely calculate radiation exposureover
the biological mean-life. For example, if 100 nCi of
14C-β-carotene, which
had the τbio of 36.1 days (equals to 51984 min), was administered to a
human subject of 61.2 kg (see Supporting Information, Table 2), the
radiation exposures to WB and liver (≈1.5 kg) were calculated by consi-
dering WT and FN as follows:
exposure to WB ¼
8:3f J =decay
61:2k g
  51984 min  
100 nCi  
2200 dpm
1n C i
  
  1   1 ¼ 1:6 μSv
exposure to liver ¼
8:3f J =decay
 1:5k g
  51984 min  
100 nCi  
2200 dpm
1n C i
  
  0:04   0:8 ¼ 2:0 μSv
All radiation exposure calculations from
14C-food component and
14C-nutrient studies are available as Supporting Information (Table 2).
14CDosingCalculationforDetectingOptimal
14CConcentration
with
14C-AMS. A
14C dose estimation was required for determining
the optimal
14C range for the
14C-AMS, which ranged from 0.01 to 100
Modernwithresolutionofe0.05ModerntotheambientModern(baseline).
The
14C dose level was calculated as follows: (3):
expected 14Cd o s eðnCiÞ¼expected Modern ðof samplesÞ 
6:11
fCi
mgC
 
1m go fC
sample volume or mass
 
total sample volume or mass   106 ð2Þ
In general, biological/biomedical AMS easily measured 10 Modern in
sample containing 1 mg of C. For example, if 10 Modern was from 25 μL
of plasma from a 70 kg human subject, if the
14C-compound was water-
soluble, which can be distributed to WB water (maximum 42 L), and if
absorption is 100%, then the
14C dose level can be calculated as
expected 14Cd o s eðnCiÞ¼10 Modern   6:11
fCi
mg of C
 
1mgC
25 μLo fp l a s m a
  42 L ðin 70 kg humanÞ 
106   103 nCi
Therefore, when the water-soluble
14Cc o m p o u n do f≈100 nCi was
dosed to a 70 kg human subject, a 25 μL plasma sample would be about
10 Modern. The formula (eq 2) can be used to estimate the amount of
14C
dose. For more complete estimation, the bioavailability and body distri-
bution of the food component or nutrient should be considered (3).
RESULTS AND DISCUSSION
Calculating Human Radiation Exposure from
14C-Nutrients.
Thedoseof
14C-nutrientsandradiationexposureswereestimated
over the biological mean-life (τbiological)( Table 2). The
14C-nutri-
entscontaining36-101.5nCiwereorallyingestedatbreakfastby
humansubjectsweighing52-116kg.Biologicalhalf-lives(t1/2)of
these nutrients ranged from 2.5 to 100 days.
Radiation exposure to WBranged from 0.12 to 5.2 μSv, which
was 4-170 times lower than that experienced during a 4 h flight
(20 μSv) (28). In general, radiation exposure increased as the
biological mean-life of nutrient increased and as the organ or
tissue mass decreased. Assuming 100% of the body’s stored
14C-nutrients was housed in liver regardless of the WT and FN,
then radiation exposure to a 1.5 kg liver was calculated to be
≈50 times higher than that to a 70 kg WB. If all of a 100 nCi
14C-β-carotene dose was converted to
14C-retinol and stored
in the liver, the radiation exposure to liver was increased
to a maximum 354 μSv (Table 2). Sequestration of 100% of the
14C label in the liver represents the “worst case” scenario.
Table 2. Estimated Radiation Exposure from
14C-Labeled Nutrients over the Biological Mean-Life (τbiological) as a Function of Time since Dose
R-tocopherol (20)
unit β-carotene (18) lutein (19) RRR all-rac folic acid (21)
subject body weight kg 76.8 ( 23.2 (n =8 ) 64.1 (n =1 ) 79.5 (n =1 ) 79.5 (n =1 ) 78.3 ( 22.3 (n =1 3 )
dose nCi 100 36 101.5 99.95 100
half-life (t1/2) day 25 14 2.5 2.5 100
mean-life (τbiological = t1/2/Ln 2) day 36.1 20.2 3.6 3.6 144.3
tissue weighting factor, WT, liver 0.04 0.04 0.04 0.04 0.04
fractional nutrient, FN, liver 0.8 (as carotene)
0.9 (as retinol)
0.5 0.8 0.8 0.333
radiation exposure
a
whole body, WB μSv 1.3 ( 0.4 0.3 0.12 0.12 5.2 ( 1.5
liver, 1.5 kg
b μSv 63.3 (as carotene)
354 (as retinol)
12.7 6.4 6.3 253
liver, 1.5 kg
c μSv 2.0 (as carotene)
12.8 (as retinol)
0.3 0.2 0.2 3.4
aNutrient absorption is assumed 100%.
bRadiation exposure regardless of WT and FN.
cRadiation exposure regard of WT (ICRP 103, 2008) and FN. The dimensionless
multiplicative factors (WT and FN) are 1 for WB.Article J. Agric. Food Chem., Vol. 58, No. 8, 2010 4635
By considering the WT and FN, radiation exposures to liver
(Table2)werecalculatedtorangefrom0.2to12.8μSv,whichwas
lowerthanthatexperiencedduringa4hflightat37000ftaltitude
(20 μSv). Although
14C-retinol had a longer half-life (140 days),
radiation exposure to liver from
14C-retinol was calculated to be
12.8 μSv when the WT (0.04 in liver) and FN (0.9 in liver) were
considered. Consequently, radiation exposure from dose with
100 nCi
14C was equal to or less than that experienced from
common/natural radiation (see Supporting Information, Table 3).
Radioactive isotopes emit energy depending on R-, β-, or
γ-decay. People are exposed to various radiation sources during
their lifetime, and the limit of annual radiation exposure differed
betweenWB,organ,ortissue(seeSupportingInformationTable3).
14C emitted an electron for each β-decay, the average energy of
which was 8.3 fJ/decay (3). Thus, the reference human (70 kg,
≈ 1.1 Modern, assumed 23% carbon content) was naturally/
constantly exposed to ≈1.7 nSv/h at the ambient
14Cl e v e l
1:1 Modern ¼
14:96 dpm
gC
 
23 gC
100 g
  70 kg  
8:3f J
dpm
 
60 min
hour
¼
120nJ
hour
,accordingly
120 nJ
hour
÷70 kg ¼
1:7 nSv
hour
where J/kg=Sv) (3).
Deposition of the radiation energy from the administered
14C-nutrient was neither complete nor constant throughout the
human body during the study because the
14C-nutrient was
metabolized, stored, and eventually excreted. The radiation
exposure from ingested
14C-nutrients or food components can
be calculated using an exponential elimination model as a func-
tion of time since dose, as long as the biological mean-lives of the
14C-labeled nutrients were shorter than the expected human life
span (3). Therefore, full dynamic/kinetic modeling was required
for the more exact calculation of human radiation exposure.
Furthermore, correction of radiation exposure due to radio-
isotope decay was not necessary when τisotope was much longer
than τbio. In addition, considering WT and FN enabled more
complete calculation than a prior calculation (3) of radiation
exposure to individual organs and tissues. In the present study,
radiation exposure to liver was 30-75 times lower when the WT
and FN of each nutrient were considered (Table 2). Finally, radi-
ation exposures to WB and liver from all
14C-nutrients (Table 2)
were lower than natural/human-made radiation exposure.
DoseCalculationforOptimal
14C-AMSMeasurementof1mgof
C Size Samples. Table 3 summarizes the calculated and measured
maximum
14C levels in human plasma, feces, or urine samples
that contained 1 mg of C. The physiological-based
14C-nutrient
study required a dose with the same or smaller amount of
14C-nutrient relative to its RDA or AI. The ratio (mol/mol) of
14C-nutrient to the RDA or AI was e1/1812 (17, 18, 20, 21),
whichwasevensmallerthanthemicrodosinglevel,1/100(25,26).
The ratio (mol/mol) of
14C-lutein to its AI ranged from 1/3 to
1/28 (19), due to the low specific activity of
14C-lutein ingested
(Table 1), and even this ratio (1/3 to 1/28) was suitable for
physiological-based pharmacokinetics and ADME measure-
ments (Table 1).
Peak
14C levels in plasma, urine, and feces occurred within the
first5daysasafunctionoftimesincedosing.Forhumansubjects
dosed with 36-100 nCi of
14C, the calculated peak of
14Ci n
plasma(mgofC) rangedfrom49to137Modernfora3Lplasma
pool,from8to23Modernforan18Linterstitialwaterpool,and
from 4 to 10 Modern for a 42 L WB water pool. The measured
level of
14C in plasma (mg of C), however, varied over a 10-
30-fold lower range, because
14C-nutrients were distributed,
metabolized, and excreted (Table 3). The measured peak range
(3.8-21 Modern) of
14C in plasma was within the optimal
14C-AMS range of 0.01-100 Modern.
In general, the maximum
14C level in feces and in urine was
higher than the maximum
14C level in plasma. Therefore, feces
andurinesamplescontaining>100Modernusuallyneededtobe
diluted with tributyrin, which was devoid of
14C. Thus, the levels
of
14C in the diluted feces and urine were within the optimal
14C-AMS working range. Masses or volumes of the feces and of
urine collections were difficult to control compared to those of
human blood. Furthermore, feces and urine collections varied
widely in their carbon content compared to human blood. Con-
sequently, the Modern values of feces and urine were higher and
more variable than those of human blood, due to the variable
concentrations ofcarbon in feces/urinesand thefirst-pass elimina-
tionof
14C-nutrientinfeces.Althoughmaximum
14Clevelsinfeces
and urine were variable depending on ADME, nutrient hydro-
phobicity, subject traits, etc., dosing of e100 nCi was suitable for
14C-AMS, the optimal range of which was 0.01-100 Modern.
In fact, determination of
14C-dose amount for optimal
14C-AMS measurement was difficult because that determination
needed to consider the hydrophilic, hydrophobic, and bioavail-
ability characteristics of nutrients, human body weight, and
sensitivity of AMS. Most nutrients would be transferred, parti-
tioned, or distributed among body organs (liver, gut, etc.),
intracellular (21 L), interstitial (18 L), intravascular fluids (3 L),
and WB water (42 L). If water-soluble compounds were distri-
buted inWBwater of42L,≈100 nCi of
14C would peakatabout
Table 3. Estimated and Measured
14C Levels from
14C-Labeled Nutrients as a Function of Time since Dose
R-tocopherol (20)
unit β-carotene (18) lutein (19) RRR all-rac folic acid (21)
dose nCi 100 36 101.5 99.95 100
estimated maximum
14C level/mg of C
(in 25 μL of plasma)
a
distributed in plasma of 3 L Modern 137 49 139 137 137
distributed in interstitial water of 18 L Modern 23 8 23 23 23
distributed in WB water of 42 L Modern 10 4 10 10 10
measured maximum
14C level/mg of C
plasma Modern 13 3.8 21 14 4.7(1.6
feces
b Modern g35 54 18 11 53( 50
urine
b Modern ≈53 1.0 0.6 1.8 66(22
aAssumed 100% absorption of
14C-nutrient since dose.
bExcept for feces and urine samples in folic acid study (21), some feces and urine samples (18-21) that were
suspected to have high
14C levels were diluted with a TRIB for optimal
14C-AMS measurement (0.01-100 Modern range).4636 J. Agric. Food Chem., Vol. 58, No. 8, 2010 Kim et al.
10Modernin 25μL ofplasma (which contained 1 mgof C), even
thoughthe bioavailability of nutrients was variable. On the other
hand, very hydrophobic compounds or compounds with e20%
bioavailability required a larger dose of ≈200 nCi to study
14C-nutrients with long biological half-life (3).
Eventhoughtheadministereddosesrangedfrom36to100nCi
in our four prior studies, by considering tissue weighting factor
and fractional nutrient factor, the radiation exposures to WB
(0.12-5.2 μSv) or to liver (0.2-3.4 μSv) were much lower than
thatfroma4haircraftflight(20μSv).Furthermore,
14C-dosesof
36-100 nCi were measured in the range of 0.01-100 Modern in
plasma, urine, and feces aliquots that contained 1 mg of C. All
materials and samples from graphitization and
14C-AMS mea-
surement can be considered nonradioactive waste materials, at
significant cost saving for disposal.
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